Publication | Open Access
AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status
29
Citations
35
References
2018
Year
Braf Genetic StatusMedicineColorectal CancerPathologyAnti-tumour EffectsCancer GenomicsTumor SuppressorCancer GeneticsOncologyRadiation OncologyTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1